abstract |
The present invention relates to arylvinyl derivatives which inhibit the activity of estrogen related receptor gamma (hereinafter referred to as "ERRĪ³"), their prodrugs, their solvates, their stereoisomers or their pharmaceutics The above-mentioned acceptable salt and the pharmaceutical composition using the novel aryl vinyl as an active ingredient. |